| (Values in U.S. Thousands) | Jun, 2017 | Mar, 2017 | Dec, 2016 | Sep, 2016 | Jun, 2016 |
| Sales | 0 | 29,980 | 0 | 0 | 0 |
| Sales Growth | -100.00% | unch | unch | unch | unch |
| Net Income | -3,710 | -8,920 | -7,710 | -7,430 | -8,480 |
| Net Income Growth | +58.41% | -15.69% | -3.77% | +12.38% | -8.16% |
(NVLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Nivalis Therapeutics, Inc. is a pharmaceutical company. The company is engaged in discovery, development and commercialization of molecule therapeutics for cystic fibrosis. Nivalis Therapeutics, Inc. is headquartered in Boulder, Colorado.